Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 4/20 | 0.65 |
| ▸ | MAPT | P10636 | 11/20 | 0.63 |
| ▸ | TP53 | P04637 | 2/20 | 0.63 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.50 |
| ▸ | PPARG | P37231 | 1/20 | 0.43 |
| ▸ | CCKBR | P32239 | 1/20 | 0.43 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL974380 | 0.84 | MAPT (0.48) | POLBMAPTTP53RXFP1KMT2A | |
| SCHEMBL972208 | 0.80 | MAPT (0.64) | POLBMAPTTP53KMT2A | |
| SCHEMBL15882461 | 0.77 | L3MBTL1 (0.61) | POLBMAPTTP53L3MBTL1PPARG | |
| SCHEMBL14569197 | 0.76 | L3MBTL1 (0.67) | POLBMAPTTP53L3MBTL1PPARG | |
| SCHEMBL15825036 | 0.75 | MAPT (0.67) | POLBMAPTTP53L3MBTL1PPARG | |
| SCHEMBL858210 | 0.73 | MAPT (0.59) | POLBMAPTTP53L3MBTL1PPARG | |
| SCHEMBL858579 | 0.73 | MAPT (0.60) | POLBMAPTTP53L3MBTL1PPARG | |
| SCHEMBL858487 | 0.72 | MAPT (0.61) | POLBMAPTTP53L3MBTL1PPARG | |
| SCHEMBL2764261 | 0.72 | L3MBTL1 (0.65) | POLBMAPTTP53L3MBTL1PPARG | |
| SCHEMBL788538 | 0.72 | L3MBTL1 (0.65) | POLBMAPTTP53L3MBTL1PPARG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110015065-A1 | Substituted Sulfonic Acid Amide Compounds | BASF SE (DE) | 2011-01-20 | — | — | US | claimed |
| US-20110015065-A1 | Substituted Sulfonic Acid Amide Compounds | BASF SE (DE) | 2011-01-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110015065-A1 | Substituted Sulfonic Acid Amide Compounds | STS, NAPA, NAAA | POLB 4080/4885MAPT 3640/4885TP53 783/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.